Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01673802 | The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma | completed | Early Phase 1 | 18 | University of Alabama at BirminghamOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT02033447 | Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men(MAGNABLATE I) | completed | Early Phase 1 | 12 | University College London HospitalsOTHER | 1 | May 10, 2017 |
| clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01034514 | 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy | terminated | Early Phase 1 | 35 | Billy W. Loo Jr.OTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00405366 | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer(NRR) | completed | Early Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01996527 | 3T MRI Biomarkers of Glioma Treatment Response | terminated | Early Phase 1 | 7 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 17, 2017 | clinicaltrials |
| NCT03113019 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer(BC-LDC) | unknown | Early Phase 1 | 26 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 0 | Apr 13, 2017 | clinicaltrials |
| NCT01527058 | 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients(GRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01737112 | 99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients(TcRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02278510 | Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma | completed | Early Phase 1 | 3 | Michael Vogelbaum, MD, PhDOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT01050842 | Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer | completed | Early Phase 1 | 18 | Mayo ClinicOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT01751529 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | completed | Early Phase 1 | 48 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT01468649 | Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer | completed | Early Phase 1 | 50 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT01878708 | A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma | terminated | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT02144623 | Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia(PREVAIL) | completed | Early Phase 1 | 4 | Lund University HospitalOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03060343 | Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) | unknown | Early Phase 1 | 10 | Yu FengleiOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02402348 | Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis | terminated | Early Phase 1 | 3 | West Virginia UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT01313039 | Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer | completed | Early Phase 1 | 4 | University of MiamiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02421575 | Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | terminated | Early Phase 1 | 4 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 2, 2017 | clinicaltrials |
| NCT02319889 | Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma | terminated | Early Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT02568033 | Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer | unknown | Early Phase 1 | 22 | The Cooper Health SystemOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT02326168 | PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer | completed | Early Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01171092 | A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | completed | Early Phase 1 | 21 | University of Kansas Medical CenterOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT01022021 | Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine | completed | Early Phase 1 | 17 | University of Kansas Medical CenterOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01209676 | IMCgp100 in Advanced Unresectable Melanoma | completed | Early Phase 1 | 1 | University of PennsylvaniaOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT00723463 | Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue | completed | Early Phase 1 | 200 | University of MichiganOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01659645 | Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast | completed | Early Phase 1 | 12 | Emory UniversityOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02380209 | An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer | terminated | Early Phase 1 | 8 | University of ArizonaOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02805868 | Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis | withdrawn | Early Phase 1 | 0 | Northwestern UniversityOTHER | 0 | Oct 24, 2016 | clinicaltrials |
| NCT02852473 | Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude | completed | Early Phase 1 | 10 | Mayo ClinicOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02929797 | Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer(AKT) | unknown | Early Phase 1 | 72 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01331590 | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | completed | Early Phase 1 | 13 | Washington University School of MedicineOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT01634126 | Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening(MY-FIT) | completed | Early Phase 1 | 2,761 | Kaiser PermanenteOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01678690 | An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors | completed | Early Phase 1 | 11 | InnoPharmax Inc.INDUSTRY | 2 | Sep 2, 2016 | clinicaltrials |
| NCT01364454 | General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening | completed | Early Phase 1 | 8,140 | Paris 12 Val de Marne UniversityOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT02419170 | Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 18, 2016 | clinicaltrials |
| NCT02447055 | Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00864864 | Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma | completed | Early Phase 1 | 8 | Massachusetts General HospitalOTHER | 1 | Jul 7, 2016 | clinicaltrials |
| NCT02277457 | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02546752 | Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine | completed | Early Phase 1 | 1,306 | Regenstrief Institute, Inc.OTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01482728 | Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer | completed | Early Phase 1 | 12 | University of VirginiaOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT02747290 | 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT02652286 | Pulmonary Artery Harmonic Ace+7 Energy Sealing in VATS Lobectomy | completed | Early Phase 1 | 20 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT01425749 | Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI(Mel55) | completed | Early Phase 1 | 25 | Craig L Slingluff, JrOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT02287168 | Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients | completed | Early Phase 1 | 34 | Bezmialem Vakif UniversityOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01962909 | Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer | terminated | Early Phase 1 | 3 | University of VirginiaOTHER | 1 | Mar 18, 2016 | clinicaltrials |
| NCT02707315 | A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | unknown | Early Phase 1 | 15 | The Cooper Health SystemOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT02704299 | The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer. | unknown | Early Phase 1 | 36 | Shanghai AbelZeta Ltd.INDUSTRY | 0 | Mar 11, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jun 1, 2017source: clinicaltrials